Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Infection.
Ning DuDan YouDava TenzingDongxiang QuJun MengYihui WangJuan HePublished in: Infection and drug resistance (2024)
Carrimycin may be a bright alternative for CRAB infection as one of the drugs in combination therapy, especially in a patient with hyperinflammatory response.